Propiedad y actividad de insiders de Artiva Biotherapeutics, Inc. (ARTV): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $8.60 |
| Capitalización | $420M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-15 | Aslan Fred | A-Award | 110,000 | |
| 2026-09-15 | Aslan Fred | A-Award | 315,000 | $2.8M |
| 2026-09-10 | Aslan Fred | A-Award | 45,000 | |
| 2026-09-10 | Aslan Fred | A-Award | 155,000 | $1.6M |
| 2026-09-10 | RA CAPITAL MANAGEMENT, L.P. | A-Award | 16,250 | $169K |
| 2026-09-10 | Stoppel Laura | A-Award | 16,250 | $169K |
| 2026-09-10 | Sorg Elaine K. | A-Award | 16,250 | $169K |
| 2026-09-10 | HOUGEN ELIZABETH L | A-Award | 16,250 | $169K |
| 2026-09-10 | DANIELS BRIAN | A-Award | 16,250 | $169K |
| 2026-09-10 | Baker Daniel G. | A-Award | 16,250 | $169K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.9M | $25.4M | $160.9M | $102.5M | $53.5M | $40.2M | $26.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $23.5M | $145.2M | $81.3M |
| Cuentas por Cobrar | 0 | 0 | $468000 | $525000 | $1.8M | $146000 | $767000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.0M | $26.1M | $162.3M | $104.7M | $79.8M | $188.6M | $112.7M |
| Inmovilizado Material | $2.5M | $2.4M | $4.1M | $27.6M | $24.6M | $20.4M | $17.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $4.8M | $29.2M | $169.9M | $133.1M | $105.1M | $209.6M | $130.9M |
| Cuentas por Pagar | $258000 | $2.2M | $1.4M | $1.1M | $614000 | $1.1M | $355000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $3.1M |
| Pasivos Corrientes | $942000 | $5.8M | $19.3M | $25.6M | $12.2M | $12.3M | $13.1M |
| Deuda a Largo | $5.6M | 0 | 0 | 0 | 0 | 0 | $7.9M |
| Pasivos Totales | $8.8M | $50.8M | $258.8M | $273.8M | $267.1M | $22.9M | $21.0M |
| Reservas | -$4.0M | -$22.0M | -$93.8M | -$152.6M | -$181.3M | -$246.7M | -$330.5M |
| Patrimonio Neto | -$4.0M | -$21.6M | -$88.9M | -$140.7M | -$162.0M | $186.6M | $110.0M |
| Deuda Total | $7.8M | $2.1M | $1.7M | $19.4M | $16.9M | $14.4M | $10.9M |
| Deuda Neta | $5.9M | -$23.3M | -$159.2M | -$83.1M | -$60.1M | -$171.1M | -$97.1M |
| Capital Circulante | $1.0M | $20.3M | $143.0M | $79.0M | $67.6M | $176.4M | $99.6M |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 24.16 |
Rentabilidad
| Rentabilidad sobre capital | -53.86% |
| Rentabilidad sobre capital invertido | -26.91% |
| Rentabilidad sobre activos | -24.64% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ADVM · ALXO · CNTB · DTIL · GUTS · IFRX · MGX
Explorar sector: Healthcare · Biotechnology
Más secciones de ARTV: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones